Binding affinity of dACE2/hACE2 to RBD and infectivity of pseudotyped and authentic viruses
SARS-CoV-2 S glycoprotein is a protein of 1273 residues. It harbors a furin cleavage site (Q677TNSPRRAR↓SV687) at the boundary between the S1/S2 subunits 13. The S1 domain contains two subdomains, the N-terminal domain (NTD) and C-terminal domain (CTD). RBD is responsible for receptor recognition, which was mapped in previous structural studies 9, 10. dACE2 shares 83.88% primary sequence identity with hACE2. It is also composed of two subdomains, the subdomains I and II (Fig. 1A). Because of the high sequence consensus between hACE2 and dACE2, we speculated that dACE2 may also be able to bind to RBD. Therefore, we determined the binding affinities between RBD to hACE2 and to dACE2. The results show that the dissociation constant (KD) between RBD and hACE2 is 18.5 nM, while that between RBD and dACE2 is 123 nM, which confirms that dACE2 can indeed bind to RBD, but with a binding affinity 6.65 time lower than hACE2 (Fig. 1B and 1C).
To test the hypothesis that dACE2 is a receptor for SARS-CoV-2, we infected the BHK21 cells transfected dACE2 with a pseudovirus bearing SARS-CoV-2 S protein. Our results showed that the fluorescence signal represented as the relative luminescence units (RLU) in the S protein-expressing BHK21 cells has a dose-dependence relation with the virus dilutions. At the virus dilution of 60 and 180, the RLU values in the dACE2 expressing BHK21 cells are significantly higher than those in the BHK21 cells without expressing dACE2 (p < 0.0001, student’s t-test), but at the virus dilutions lower that 180, no statistic difference between the BHK21 cells expressing dACE2 and without expressing dACE2 is observed (Fig. 1D). In contrast, the SARS-CoV-2 S protein-bearing pseudovirus infection leads to significantly higher RLU values in the hACE2-expressing BHK21 than in those without expressing hACE2 (Fig. 1E). These results suggest that the pseudovirus bearing the SARS-CoV-2 S protein can infect the dACE2 expressing cells, but with a less efficiency than infect the hACE2 expressing cells. They are consistent to our SPR results showing that the affinity of SARS-CoV-2 S protein to dACE2 is lower than to hACE2 (Fig. 1B and 1C).
When infected with the authentic SARS-CoV-2, the number of copies of the SARS-CoV-2 ORF1ab significantly increase in the HeLa cells expressing either dACE2 or hACE2 at 48 and 72 h after infection, compared with those not expressing these two molecules (Fig. 1F). These results confirm that dACE2 is indeed a cellular receptor that supports SARS-CoV-2 infecting host cells, just as its human ortholog, the hACE2.
The Overall Structure Of DACE2 In Complex With RBD
In order to elaborate the structural basis for dACE2 binding to RBD, we determined the crystal structure for the RBD/dACE2 complex(Fig. S1A). The RBD/dACE2 complex was prepared with size exclusion chromatography and the structure was solved to 3.0 Å resolution (Table S1), with one RBD binding to a single dACE2 molecule in the asymmetric unit. For dACE2, clear electron densities could be traced for 596 residues from S19 to Y706 and L721 to G725 as well as glycans N-linked to residue N342, while the electron densities for R707 to S720 is invisible. The structure for RBD in the complex includes residues T333 to P526, all of which have clear density. The overall structure of RBD/dACE2 is very similar to previously reported RBD/hACE2 (PDB ID: 6LZG) with a RMSD of 0.654 (Fig. S1B).
The RBD in the RBD/dACE2 complex structure protein shows the same fold with that in the ARS-CoV-2-RBD/hACE2 complex previous reported. It is divided into two subdomains: the β-sheet-dominated conserved core domain, which is stabilized by a disulfide bond between βc2 and βc4, and the loop-dominated external domain, which contains two small β-sheets. The dACE2 also share similar architecture with hACE2 in the RBD/hACE2 complex: it is divided into subdomain I, which interact with RBD and subdomain I, the catalyzing subdomain (Fig S1C and S1D).
The interaction interface between dACE2 and RBD and comparison with the RBD/hACE2complex
We analyzed the atomic contacts between dACE2 and RBD in the crystal structure of dACE2/RBD with a cutoff distance of 4 Å. In the complex, 18 dACE2 residues (Q19, L23, T26, F27, E29, K30, Y33, E36, E37, Y40, Q41, T81, Y82, E325, N329, K352, D354 and R356) form atomic contacts with 18 RBD residues (R403, K417, G446, Y449, Y453, L455, F456, A475, F486, N487, Y489, G496, Q498, T500, N501, G502, Y505 and Q506) (Fig. 2A). The total number of atomic contacts between dACE2 and RBD is 127 (Table S2 and S3). Among these contacts, 118 are Van der Waals (vdw) interactions, and 14 are hydrogen bonds (H-bonds) or salt bridges (Table S2 and S3). The contact interface in RBD has a saddle shape with two protrusive side parts and a recessed center part, and can be divided into two contact regions (CRs), CR1 (R403, G446, Y449, Q498, T500, N501, G502 and Q506) and CR2 (K417, Y453, L455, F456, F486, N487 and Y489) (Fig. 2C-2D). CR1 is mainly composed of polar residues. In this region, K403 forms a hydrogen bond with dACE2 residueY33; Q498 forms hydrogen bonds with dACE2 residues E37, Q41 and K352; and G502 forms hydrogen bonds with K352 (Fig. 2C). Other polar atomic contacts between CR1 and dACE2 include G446 interacting with Q41, Y449 with E37 and Q41, G502 with G353, and Q506 with E325.
Different from the CR1, the CR2 is mainly composed of hydrophobic and aromatic residues. In CR2, residue K471 forms a salt bridge with dACE2 E29; N487 forms a hydrogen bond with Y82 (Fig. 2C). Other atomic contacts between CR2 and dACE2 involves CR2 Y453 interacting with dACE2 H34, N487 with L23, L455 with E29 and H33, F456 with T26 and E29, F486 with T81 and T82, and Y489 with T26 F27, K30 and Y82 (Fig. 2C). Generally, the RBD CR1 and CR2 interact with two overlapping contact regions in dACE2, CR1’ and CR2’, respectively (Fig. 2A and 2C).
In comparison, in the crystal structure of RBD/hACE2 complex, 20 residues in hACE2 (S19, Q24, T27, F28, D30, K31, H34, E35, E37, D38, Y41, Q42, Q45, M82, Y83, N330, K353, G354, D355, R357) form atomic contacts with 19 RBD residues (K417, G446, Y449, Y453, L455, F456, A475, G476, F486, N487, Y489, F490, Q493, G496, Q498, T500, N501, G502, Y505). To be noticed, the residue T20 in hACE2 is missing in dACE2, so the residue number of dACE2 is one less than hACE2 after position 20 (Fig. S2). The total number of atomic contacts between RBD and hACE2 is 145, among which 16 are hydrogen bonds or salt bridges (Table S2 and S3). Compared with the RBD in the RBD/dACE2 structure, the CR1 (G446, Y449, G496, Q498, T500, N501 and G502) of the RBD in the RBD/hACE2 structure does not include R403 and Q506, but includes G496 which the former does not include; and the CR2 (K417, Y453, L455, F456, A475, F486, N487, Y489, F490, and Q493) includes F490, A475 and Q493 which the CR2 in the RBD/dACE2 structure does not include. In the RBD/hACE2 structure, the RBD CR1 residue Y449 forms a H-bond with hACE2 residues D38 and Q42; G496 forms a H-bond with K353; Q498 forms a H-bond with Q42, N501 forms a H-bond with Y41, and G502 forms a H-bond with K352. Besides, CR1 T500 forms strong vdw contacts with Y41, N330, D355, R357. In CR2 of this structure, K417 also forms a salt bridge with hACE2 D30; A475 forms a H-bond with S19; N487 forms a H-bond with Q24 and Y83. Other atomic contacts between CR2 and hACE2 include CR2 Y453 and L455 interacting with hACE2 H34, F456 with T27, D30, K31; F486 with M82 and Y83; F490 with K31; and Q493 with H34 and E35. The contact residues in hACE2 can also be grouped into two contact regions, CR1’ and CR2’, which are not overlapping (Fig. 2B and 2D).
We further analyzed the difference in the interface residue contacts at specific positions of dACE2 and hACE2 (Fig. 3). It revealed that dACE2 S19 only makes a vdw contact with SARS-CoV-2 RBD, while hACE2 S19 not only makes vdw contacts with A475 and G476, but also forms a hydrogen bond with A475 (Fig. 3A). Moreover, dACE2 L23 makes 3 vdw contacts with A475 and N487, but the corresponding hACE2 Q24 forms a hydrogen bond with N487 and 7 vdw contacts with A475 and N487 (Fig. 3B). dACE2 E29 forms a hydrogen bond and a salt bridge with K417, and the corresponding hACE2 D30 forms a hydrogen bond and two salt bridges with K417 (Fig. 3C). Additionally, dACE2 Y33 interacts with R403, Y453 and L455, while hACE2, whereas the corresponding hACE2 H34 interact with Y453, L455 and Q493 (Fig. 3D). Furthermore, dACE2 E34 does not contact with any SARS-CoV-2 RBD residue, whereas the corresponding hACE2 E35 contacts with Q493 (Fig. 3E). What is more, dACE2 E325 interacts with N501 and Q506, whereas the corresponding hACE2 G326 does not contact with any SARS-CoV-2 RBD residue (Fig. 3F).
In summary, slightly fewer residues are involved in forming the interaction interface in the SARS-CoV-2 RBD/dACE2 complex (18 SARS-CoV-2 RBD residues and 18 dACE2 residues) than those in the SARS-CoV-2 RBD/dACE2 complex (19 SARS-CoV-2 RBD residues and 20 dACE2 residues, and the total number of atom contacts, hydrogen bonds and salt bridges in the SARS-CoV-2 RBD/dACE2 (127, 13, 1, respectively) are also less than those in the SARS-CoV-2 RBD/dACE2 complex (145, 15, 2, respectively).
Effect of RBD interface residue mutations on its binding affinity to dACE2 or hACE2
As mentioned above, at the RBD/dACE2 and RBD/hACE2 interfaces, there is a conserved salt bridge, which is formed by RBD K417 and hACE D30 or dACE E29. Salt bridges are among the strongest non-covalent bonds in protein interface interactions. To address the role of these salt bridges on the affinity of the binding partners, we introduced K417V or K417N mutations which are found in some SARS-CoV-2 isolates (Fig. S3A) to RBD and examined the binding affinity of these mutants to hACE2 and dACE2 by Surface plasmon resonance (SPR). The results showed that the KD of RBD with K417V and K417N mutations to dACE2 are 400 nM and 507 nM, respectively (Fig. 4A and 4B). Compared to the KD of the wide type (wt) RBD to dACE2 (123 nM, Fig. 1C), these values are 3.25 and 4.12 times higher, respectively, suggesting that the salt bridge disruption significantly reduces the affinity of RBD to dACE2. Similarly, the KD of RBD with K417V and K417N to hACE2 are 53.4 nM and 49.7 nM (Fig. 4E and 4F), which near 3 times decrease compared to the binding affinity the wt RBD to hACE2 (Fig. 1B). These results confirm that the disruption of the conserved salt bridge indeed reduces the affinity of RBD to both dACE2 and hACE2.
To be noticed, the KD value of RBD N501Y mutant, which is also detected in SARS-CoV-2 stains (Fig. S3B), binding to dACE2 and hACE2 are 37.1 and 0.881 nM (Fig. 4C and 4G), which are 3.32 and 21.00 times less than those of wt RBD to dACE2 and hACE2, respectively. Therefore, N501Y mutation enhances the affinity of RBD to both dACE2 and hACE2, among which, the augment is specifically significant for hACE2.
To confirm the effect of RBD mutations on the binding capacity to native formatted ACE2, we measured the binding of RBD mutants to ACE2s expressed on 293T cell surface by by flow cytometer (Fig. 4D, 4H and S4). The results show that the percentage of the RBD K417N mutant-binding dACE2-positive HEK293T cells was significantly lower than that of wt RBD binding dACE2-positive cells. Wheareas, the percentage of the RBD N501Y mutant binding dACE2-positive HEK293T cells was significantly higher than that of wt RBD binding dACE2-positive cells. Similarly, among hACE2-positive HEK293T cells, the percentage of both the RBD K417N and K417V mutant-binding cells were significantly lower than that of the wt RBD-binding cells, while the RBD N501Y mutant-binding cells was significantly higher than that of the wt RBD-binding cells. These results again confirmed the importance of RBD interface residues at positions 417 and 501 for determination of the binding affinity to both dACE2 and hACE2 receptors.